November 4, 2025
Zelluna ASA – Mandatory notification of trade
Reference is made to the private placement (the “Private Placement”) and the retail offering through PrimaryBid (the “PrimaryBid Offering”) announced by…
Pharmaceuticals, Biotechnology and Life Sciences
Reference is made to the private placement (the “Private Placement”) and the retail offering through PrimaryBid (the “PrimaryBid Offering”) announced by…
SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on…
Successful private placement and retail offering – Zelluna ASA raises NOK 58 million to advance the world’s first “off-the-shelf” TCR-NK…
— HUTCHMED unveils its innovative ATTC platform, potentially providing precision oncology with synergistic dual-mechanism of action — — Lead candidate…
Investor webcast to be held on Monday November 3, 2025 at 8:00 am ESTHAYWARD, Calif., Nov. 02, 2025 (GLOBE NEWSWIRE)…
REYKJAVIK, Iceland, Nov. 02, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and…
REYKJAVIK, ICELAND (November 2, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar…
MHRA response is based on the Phase 3 DRAGON interim analysis results Topline final data expected in Q4 2025 SAN DIEGO,…
COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and…
TEL AVIV, Israel, Oct. 31, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that…